Controlling Chronic Diseases related to Metabolic Disorders
The aim of METABO is to set up a comprehensive platform, running both in clinical settings and in every-day life environments, for continuous and multi-parametric monitoring of the metabolic status in patients with, or at risk of...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TIN2014-54806-R
DESARROLLO DE SISTEMAS ADAPTATIVOS Y BIOINSPIRADOS PARA EL C...
50K€
Cerrado
RTC2019-007406-1
DESARROLLO DE UNA HERRAMIENTA PARA LA DETERMINACION DE RIESG...
677K€
Cerrado
PROMINENT
Personalised Medicine in Diabetic Chronic Disease Management
3M€
Cerrado
PDC2021-121470-C21
PREDICCION DE GLUCOSA SIN INTERVENCION DEL USUARIO PARA EL A...
69K€
Cerrado
PEPPER
Patient Empowerment through Predictive PERsonalised decision...
4M€
Cerrado
PAL
Personal Assistant for healthy Lifestyle PAL
5M€
Cerrado
Información proyecto METABO
Líder del proyecto
MEDTRONIC IBERICA SA
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
10M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The aim of METABO is to set up a comprehensive platform, running both in clinical settings and in every-day life environments, for continuous and multi-parametric monitoring of the metabolic status in patients with, or at risk of, diabetes and associated metabolic disorders.The type of parameters that will be monitored, in addition to traditional clinical and biomedical parameters, will also include subcutaneous glucose concentration, dietary habits, physical activity and energy expenditure, effects of ongoing treatments, and autonomic reactions.The data produced by METABO will be integrated with the clinical data and the history of the patient and will be used in two major interrelated contexts of care:1.\tSetting up a dynamic model of the metabolic behavior of the individual to predict the influence and relative impact of specific treatments and of single parameters on glucose level.2.\tBuilding personalized care plans integrated in the current clinical processes linking the different actors in primary and secondary care and improving the active role of the Patient.